90105-41-2Relevant articles and documents
PEPTIDOMIMETIC COMPOUNDS AND ANTIBODY-DRUG CONJUGATES THEREOF
-
, (2015/07/07)
This invention relates to peptidomimetic linkers and anti-body drug conjugates thereof, to pharmaceutical compositions containing them, and to their use in therapy for the prevention or treatment of cancer.
One-Carbon Chain Extension of Esters to α-Chloroketones: A Safer Route without Diazomethane
Wang, Dengjin,Schwinden, Mark D.,Radesca, Lilian,Patel, Bharat,Kronenthal, David,Huang, Ming-Hsing,Nugent, William A.
, p. 1629 - 1633 (2007/10/03)
The reaction of a variety of methyl esters with dimethylsulfoxonium methylide at 0-25 °C affords the chain-extended β-keto dimethylsulfoxonium ylides. Subsequent treatment with hydrogen chloride in THF proceeds with loss of DMSO to afford the corresponding α-chloroketones. This sequence has been utilized to convert the methyl esters of CBZ-protected alanine and valine to the anti N-protected α-amino epoxides, which are important pharmaceutical intermediates. When the same protocol is applied to BOC-protected phenylalanine methyl ester, epimerization occurs so that the use of a more reactive aryl ester is required. This chemistry provides a practical route to α-chloroketones that avoids the use of toxic and explosive diazomethane.
NEW SYNTHESIS OF PEPTIDE SUBSTRATES AND INHIBITORS OF HUMAN GRANULOCYTE ELASTASE
Martynov, V. F.,Leont'eva, L. I.,Sorochinskaya, E. I.,Smirnov, A. O.
, p. 384 - 388 (2007/10/02)
-